Paper39288128
Elucidating the effect of drug-induced mitochondrial dysfunction on insulin signaling and glucose handling in skeletal muscle cell line (C2C12) in vitro.
Kuretu A and 3 others. PLoS One, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Elucidating the effect of drug-induced mitochondrial dysfunction on insulin signaling and glucose handling in skeletal muscle cell line (C2C12) in vitro. Papers, record 39288128. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39288128
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Elucidating the effect of drug-induced mitochondrial dysfunction on insulin signaling and glucose handling in skeletal muscle cell line (C2C12) in vitro.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulin | Major topic |
| Signal Transduction | Major topic |
| Glucose | Major topic |
| Mitochondria | Major topic |
| Reactive Oxygen Species | Major topic |
| Mice | |
| Animals | |
| Cell Line | |
| Glucose Transporter Type 4 | |
| Muscle, Skeletal | |
| Membrane Potential, Mitochondrial | |
| Proto-Oncogene Proteins c-akt | |
| Insulin Resistance | |
| Adenosine Triphosphate |
Source PubMed
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26765416 | Plasma Efavirenz Concentrations Are Associated With Lipid and Glucose Concentrations. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/26765416 | PubMed |
| 2 | 14512440 | Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes. | Circ Res | 2003 | https://conductscience.org/library/papers/14512440 | PubMed |
| 3 | 22023389 | The cellular and molecular mechanisms for neutropenia in Barth syndrome. | Eur J Haematol | 2012 | https://conductscience.org/library/papers/22023389 | PubMed |
| 4 | 11850253 | Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11850253 | PubMed |
| 5 | 31130874 | Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet. | Front Physiol | 2019 | https://conductscience.org/library/papers/31130874 | PubMed |
| 6 | 16612386 | Reactive oxygen species have a causal role in multiple forms of insulin resistance. | Nature | 2006 | https://conductscience.org/library/papers/16612386 | PubMed |
| 7 | 18957532 | Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. | Diabetes Care | 2009 | https://conductscience.org/library/papers/18957532 | PubMed |
| 8 | 18309108 | Role of mitochondrial dysfunction in insulin resistance. | Circ Res | 2008 | https://conductscience.org/library/papers/18309108 | PubMed |
| 9 | 21116967 | Assay to detect lipid peroxidation upon exposure to nanoparticles. | Methods Mol Biol | 2011 | https://conductscience.org/library/papers/21116967 | PubMed |
| 10 | 36798477 | Protective Effects of Rifampicin and Its Analog Rifampicin Quinone in a Mouse Model of Obesity-Induced Type 2 Diabetes. | ACS Pharmacol Transl Sci | 2023 | https://conductscience.org/library/papers/36798477 | PubMed |
| 11 | 24220496 | Cardiolipin-dependent formation of mitochondrial respiratory supercomplexes. | Chem Phys Lipids | 2014 | https://conductscience.org/library/papers/24220496 | PubMed |
| 12 | 29319042 | Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management. | Lung India | 2018 | https://conductscience.org/library/papers/29319042 | PubMed |
| 13 | 30677459 | Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis. | J Hepatol | 2019 | https://conductscience.org/library/papers/30677459 | PubMed |
| 14 | 23963694 | A review of the toxicity of HIV medications. | J Med Toxicol | 2014 | https://conductscience.org/library/papers/23963694 | PubMed |
| 15 | 34266386 | MitoTox: a comprehensive mitochondrial toxicity database. | BMC Bioinformatics | 2021 | https://conductscience.org/library/papers/34266386 | PubMed |
| 16 | 32061820 | Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. | Diabetes Res Clin Pract | 2020 | https://conductscience.org/library/papers/32061820 | PubMed |
| 17 | 25295011 | Skeletal muscle tissue engineering: strategies for volumetric constructs. | Front Physiol | 2014 | https://conductscience.org/library/papers/25295011 | PubMed |
| 18 | 24251116 | Biological markers of oxidative stress: Applications to cardiovascular research and practice. | Redox Biol | 2013 | https://conductscience.org/library/papers/24251116 | PubMed |
| 19 | 36860368 | Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/36860368 | PubMed |
| 20 | 33826918 | The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia. | Cell Metab | 2021 | https://conductscience.org/library/papers/33826918 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42666750 | Enhanced glucose uptake promotes the survival of hepatocellular carcinoma cells following incomplete radiofrequency ablation. | Mol Cell Oncol | 2026 | https://conductscience.org/library/papers/42666750 | PubMed |
| 41757484 | Main Protease From SARS-CoV-2 Dysregulates Glucose Handling in the C2C12 Cell Line In Vitro: A Mechanistic Study. | Immun Inflamm Dis | 2026 | https://conductscience.org/library/papers/41757484 | PubMed |
| 41155876 | Emerging Insulin Analogues: A Glimpse into How Insulin Analogues May Look in the near Future. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41155876 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| SLC2A4 | 6517 | PubTator's text mining | https://conductscience.org/library/genes/6517 | NCBI Gene |
| TAFAZZIN | 6901 | PubTator's text mining | https://conductscience.org/library/genes/6901 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39288128
GET https://conductscience.org/api/papers/v1/39288128/references?page=2